欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/1933/001
药品名称Covaxis/Triaxis/Adacel
活性成分
    • Aluminium phosphate 1.5 mg
    • diphtheria toxoid, adsorbed 2.0 IU
    • filamentous haemagglutinin of bordetella pertussis 5.0 µg
    • fimbrial-2 and -3 antigens of Bordetella pertussis 5.0 µg
    • pertactin 3.0 µg
    • Pertussis toxoid 2.5 µg
    • Tetanus toxoid 20.0 IU
剂型Suspension for injection
上市许可持有人Sanofi Pasteur Europe 14 Espace Henry Vallée 69007 Lyon Frankreich
参考成员国 - 产品名称Germany (DE)
Covaxis
互认成员国 - 产品名称
    • Netherlands (NL)
      Covaxis
许可日期2009/12/11
最近更新日期2024/11/01
药物ATC编码
    • J07AJ52 pertussis, purified antigen, combinations with toxoids
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Biological: Vaccine
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase